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 ABSTRACT 
PATIENT AND TREATMENT RELATED FACTORS RESPONSIBLE 
FOR RADIATION PNEUMONITIS IN POSTMASTECTOMY 
RADIATION AND THE IMPACT OF SUPRACLAVICULAR 
RADIATION 
Dr. Anupama Reddy P.S, Cancer institute (WIA) 
Aim: 
To Study the incidence of symptomatic and radiological pneumonitis in patients 
receiving post mastectomy loco regional radiation. 
Materials and Methods: 
 Retrospective analysis of 152 patients treated with adjuvant post-
mastectomy radiation from January 2015 to August 2016 was done. All patients 
received loco-regional radiation using single iso-centric photon three-
dimensional conformal radiation to a total dose of 4680cGy. Two plans with 
and without addition of supraclavicular (SCL) region were also generated for 30 
patients and Dose volume histogram (DVH) parameters including lung volume 
and Mean Lung Dose (MLD)for all patients  were analysed. Chest radiographs 
done prior and one year after completion of radiation were reviewed for 
radiation pneumonitis  and scored as per Modified WHO Grading System for 
Radiographic Pulmonary Toxicity (RPT). Other patient related parameters like 
age, side of treatment, comorbid illness, chemotherapy and hormonal therapy 




At a median follow up of 21 months, none had symptomatic pneumonitis. At 1 
year of completion of radiation 26 patients developed RPT (17.1%). The 
average MLD with and without SCL is 14.9Gy and 13.5Gy respectively. 24 
developed RP in tangential field territory and 2 developed in SCL territory. 
Increased age was significantly associated with development (P<0.001) and 
severity (P=0.083) of RPT. Patients irradiated on Right side were less 
associated with RPT (p=0.037), RPT was more commonly associated with 
patients exposed to Tobacco/passive smoking (p<0.001) and bronchial asthma 
(p=0.012). With a lung constraint of V20< 30% and MLD < 15 Gy none of the 
DVH parameters was associated with development of RPT.  CMF 
chemotherapy (p=0.06) and Aromatase inhibitors-Letrozole (p=0.05) were 
associated with increased development of RPT which may be due to the elderly 
group of patients receiving these therapies.  
Conclusion: 
There was no symptomatic pneumonitis and incidence of Radiation Pulmonary 
toxicity was only 17.1%. It was observed that age>50years was a significant 
factor for development of RPT. Other factors like bronchial asthma, exposure to 
passive smoking and irradiation of left side are also associated with 
development of RPT.  Addition of regional radiation did not increase RPT.  
Prospective studies are required as consensus guidelines regarding factors 
responsible for radiation pneumonitis are not available. 
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